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Background: To determine whether healthcare resources are allocated fairly, it is helpful to have information on
the quality of life (QoL) of patients with Unexplained Physical Symptoms (UPS) and on the costs associated with
them, and on how these relate to corresponding data in other patient groups. As studies to date have been limited
to specific patient populations with UPS, the objective of this study was to assess QoL and costs in a general
sample of patients with UPS using generic measures.
Methods: In a cross-sectional study, 162 patients with UPS reported on their QoL, use of healthcare resources and
lost productivity in paid and unpaid work. To assess QoL, the generic SF-36 questionnaire was used, from which
multidimensional quality-of-life scores and a one-dimensional score (utility) using the SF-6D scorings algorithm were
derived. To assess costs, the TiC-P questionnaire was used.
Results: Patients with UPS reported a poor QoL. Their QoL was mostly decreased by limitations in functioning due
to physical health, and the least by limitations in functioning due to emotional problems. The median of utilities
was 0.57, and the mean was 0.58 (SD = .09).
The cost for the use of healthcare services was estimated to be €3,123 (SD = €2,952) per patient per year. This cost was
enlarged by work-related costs: absence from work (absenteeism), lower on-the-job productivity (presenteeism), and
paid substitution of domestic tasks. The resulting mean total cost was estimated to be €6,815 per patient per year.
Conclusions: These findings suggest that patients with UPS have a high burden of disease and use a considerable
amount of healthcare resources. In comparison with other patient groups, the QoL values of patients with UPS were
among the poorest and their costs were among the highest of all patient groups. The burden for both patients and
society helps to justify the allocation of sufficient resources to effective treatment for patients with UPS.
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Unexplained Physical Symptoms (UPS), such as chronic
fatigue syndrome, are physical symptoms that cannot
be explained on the basis of a known medical condition.
The estimated prevalence of UPS ranges from 20 to
74% in primary care [1], and is 52% in secondary care
[2,3]. As UPS reduces not only Quality of Life (QoL) of
patients [4-9] but also increases costs [9-11], UPS is a
burden to patients and society alike. Information on the
burden of diseases is important, as the allocation of
healthcare resources to patient groups is partly based
on who has ‘the highest burden’, which is considered an
egalitarian and thus ‘fair’ distribution of healthcare re-
sources [12,13]. Therefore, information is needed on
the QoL of patients with UPS, on the costs associated
with them, and on how these relate to corresponding
data in other patient groups.
Studies [4-9] show that the Quality of Life (QoL) of pa-
tients with UPS is poor. To explore how this relate to the
QoL in other patient groups, the different domains of QoL
should be summarized into a one-dimensional weighted
score, so-called ‘utility’ [14,15]. In a utility, one represents
full health and zero is equivalent to death. We found three
studies that calculated utilities for patients with UPS
[4,16,17]. One study [16] was conducted in a rehabilitation
clinic and defined patients with UPS as ‘psychosomatic’ pa-
tients, who were treated for depression, anxiety, and other
mental disorders. They found a mean utility of 0.54. The
second [4] was conducted in primary care and defined UPS
as a somatoform disorder, but it excluded the most preva-
lent somatoform disorder: the undifferentiated somatoform
disorder [7]. They found a mean utility of 0.70. The third
study [17] was conducted in primary care and recruited pa-
tients – some of whom were considerably disadvantaged
socioeconomically – from general practices in London.
They found a mean utility of 0.47.
Costs to society are incurred by the healthcare services
attended by patients with UPS. One study [9] found
$4,700 annual healthcare expenditure per patient; an-
other found $5,678 [10]. Little is known about the less
visible societal costs associated with UPS due to lost
productivity in paid and unpaid work. For chronic fa-
tigue syndrome, Reynolds et al. [11] estimated that the
annual societal costs for lost labor force and household
productivity in the United States were $9.1 billion, which
amounted to approximately $20,000 per patient [11]. It
is unknown whether the cost associated with chronic fa-
tigue syndrome is representative for the overall group of
patients with UPS.
Since studies to date have been limited to specific pa-
tient populations with UPS, the objective of this study
was to assess QoL and costs in a general sample of pa-
tients with UPS using generic measures. We investigated
the objective with the following research questions:1. What is the QoL of patients with UPS?
2. What are the healthcare-related costs associated
with patients with UPS?
3. What are the work-related costs associated with
patients with UPS?
4. What is the mean total cost per patient with UPS
per year?
Methods
Study design
The cross-sectional study was part of a randomized con-
trolled trial on the effectiveness of cognitive-behavioral
group training for patients with UPS [18]. As part of the
baseline measurement, patients were asked to complete
self-report questionnaires on QoL and costs. A more de-
tailed description of the study protocol [19] has been
published elsewhere.
Study population
Between February 2005 and September 2008, patients
were recruited in general practices, outpatient clinics at
general hospitals, and at the Riagg Rijnmond, a second-
ary community mental-health service for the greater
Rotterdam area (the Netherlands). Both the attention of
physicians and of patients with UPS was drawn to the
randomized controlled trial on the effectiveness of
cognitive-behavioral group training for UPS. Physi-
cians’ attention was drawn to the group training by
periodical postcards informing them when and how
they could refer patients to the group training. Patients’ at-
tention was drawn to the group training by announce-
ments in local newspapers and on websites of patients’
associations, in which they were asked to make an ap-
pointment with their physician to discuss referral when
interested. General practitioners and medical specialists
were asked to refer those patients, who were aged be-
tween 18 and 65 years, and whose physical symptoms,
according to their clinical judgment, could not suffi-
ciently be explained on the basis of a known medical
condition. Patients were included if they signed the in-
formed consent and if their UPS fulfilled the DSM-IV
criteria for an undifferentiated somatoform disorder or
a chronic pain disorder.
We chose to use undifferentiated somatoform disorder
and chronic pain disorders for the definition of UPS and
excluded the other somatoform disorders. The reason to
define UPS in this way was, that the prevalence of un-
differentiated somatoform disorder and chronic pain
disorder is higher [7] and their DSM-IV criteria have
more similarity than the other somatoform disorders.
By defining UPS in this way, we had the largest, most
homogeneous, and clinical relevant sample based on the
internationally agreed DSM-IV criteria developed for re-
search, clinical practice, and education. Our definition for
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the DSM-5 also combined some but not all somatoform
disorders and labeled them complex somatic symptom
disorder.
To verify whether UPS fulfilled the DSM-criteria for
undifferentiated somatoform disorder or chronic pain
disorder, we used the Structured Clinical Interview
for DSM-IV Axis I Disorders (SCID-I) [20], a semi-
structured validated interview for making the major
DSM-IV Axis I diagnoses. Patients were excluded if
they did not provide informed consent, or if poor lan-
guage skills or handicaps such as cognitive impairment
prevented them from accomplishing the tasks required
by the study.
Outcome measures
The QoL in different domains was measured using the
36-item Medical Outcomes Study Short-Form General
Health Survey (SF-36) [21], a validated and reliable self-
report questionnaire for QoL, designed to be used across
a wide range of different populations [22]. The responses
to the 36 items of this questionnaire are converted into
eight multi-item subscales: ‘Physical functioning’, ‘Role
functioning physical’, ‘Bodily pain’, ‘General health’, ‘Vi-
tality’, ‘Social functioning’, ‘Role functioning emotional’,
and ‘Mental health’. Raw scale scores are linearly trans-
formed into a 0-to-100 scale, a higher score indicating a
better QoL.
To extract utilities from the SF-36, a smaller version
of the SF-36 has been developed by using eleven SF-36
items to cover six dimensions (‘SF-6D’): ‘Physical func-
tioning’, ‘Role limitations’, ‘Social functioning’, ‘Pain’, ‘Men-
tal health’, and ‘Vitality’ [23]. Each dimension has between
four and six response levels, thereby providing 18,000 pos-
sible quality-of-life states. A selection of these states was
valued as more or less preferable by a representative sam-
ple of the UK general population using a valuation tech-
nique known as ‘Standard Gamble’. On the basis of their
valuations, the utilities for all 18,000 possible health states
have been estimated using regression models. As a result,
the SF-6D outcomes can now be transformed into a utility
where one represents full health, and zero is equivalent to
death.
Costs were measured using the 2002 version of the
Trimbos/iMTA Questionnaire for Costs associated with
Psychiatric Illness (TiC-P), a self-report questionnaire
for assessing the costs of illness: it has 29 questions and
semi-fixed-response alternatives [24].
The first part of the TiC-P measures the healthcare-
related costs incurred through the use of healthcare ser-
vices and medication over the past four weeks. Hereby
patients are asked whether they had a consult with a
particular healthcare provider. If they had, the next
question inquires after the number of consultation withthis healthcare provider during the past four weeks. By
multiplying the number of consultations with the matching
reference prices for the particular consultation described in
the manual for costing studies [25] and the TiC-P manual
[26], the healthcare-related costs are estimated.
The second part, which is based on the short form of
the Health and Labor Questionnaire, measures the
work-related costs caused over the past two weeks by
absenteeism (absence from work), by presenteeism (re-
duced efficiency at work), and by substitution of do-
mestic tasks.
 For the work-related cost due to absenteeism, pa-
tients are asked whether they have a paid job. If they
have, the next questions inquire after the number of
working hours and working days per week. Subse-
quently, patients are asked whether they had any
disability days due to their health problems during
the past two weeks, and, if so, the next questions
inquire after the number of disability days in this
period and the date when reporting ill. By multiply-
ing the number of lost working hours due to ab-
sence through illness with the average productivity
cost per patient based on gender and age described
in the TiC-P manual [26], the work-related cost due
to absenteeism is estimated.
 For the work-related cost due to presenteeism, pa-
tients with a paid job are asked whether they were
less efficiently at work due to their health problem
during the past two weeks. If they were, the next
question inquires after the number of hours lost to
this inefficiency. By multiplying the number of lost
working hours due to reduced efficiency at work
with the average productivity cost per patient based
on gender and age, the work-related cost due to
presenteeism is estimated.
 For the work-related cost due to substitution of do-
mestic tasks, patients are asked whether they were hin-
dered in their domestic tasks due to their health
problems during the past two weeks. If they were, the
next questions inquire after by whom they were re-
placed and how many hours were substituted. By
multiplying the number of substituted hours by the
matching reference price for the particular paid profes-
sional [25], the work-related cost due to substitution of
domestic tasks by paid professionals is estimated.
The TiC-P manual [24] recommends to assess costs at-
tributable to health problems in general instead of the tar-
get disease only for the following reasons: 1) comorbidity is
common in psychiatric illness; and 2) patients have diffi-
culties in distinguishing healthcare consumption and pro-
duction loss due to the target disease from those due to
other health problems.
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The study has been approved by the Erasmus Medical
Research Ethics Committee and has been registered in
the Dutch Trial Register (NTR1609) [27]. Patients in this
study gave written informed consent.Statistical analyses
First, the different domains of QoL were assessed by
calculating the means and the standard deviations of
the SF-36 subscales. The overall QoL was analyzed by
calculating the median, mean and standard deviation of
SF-6D.
Second, the healthcare-related costs were indexed for
2007 using the price index figures available online on Statis-
tics Netherlands [28,29], after which the mean and the
standard deviation of the sum of healthcare-related costs
per year were calculated.
Third, the work-related costs of patients with UPS
comprise costs caused by loss of productivity in paid
work (absenteeism and presenteeism) and costs caused
by loss of productivity in unpaid work (substitution of
domestic tasks).
For the calculation of work-related cost due to ab-
senteeism, the friction-cost method was used [24,30].
The friction-cost method assumes that every working
person who is absent for 23 weeks and more is re-
placed by a formerly unemployed person and is there-
fore excluded from the cost calculations. The work-
related cost due to absenteeism was indexed for 2007
using price index figures for labor available online on
Statistics Netherlands [31], after which the mean and
the standard deviation of this cost per year were calcu-
lated. The work-related cost due to presenteeism was
also indexed for 2007 using price index figures for
labor available online on Statistics Netherlands [31],
after which the mean and the standard deviation of this
cost per year were calculated. The work-related cost of
productivity loss in unpaid work was calculated only if
domestic tasks were substituted by paid professionals
[25]. The cost for paid substitution of domestic task
was indexed for 2007 using price index figures for
labor available online on Statistics Netherlands [31],
after which the mean and standard deviation of this
cost per year were calculated.
Fourth, the mean total cost per year was the sum of
annual costs due to healthcare utilization and lost prod-
uctivity in paid and unpaid work.Results
Patient characteristics
Table 1 shows the characteristics of the 162 patients en-
rolled in the study. Due to missing answers, the SF-6D
could not be calculated for five patients (3%).Quality of life
Table 2 summarizes the SF-36 subscale means and stan-
dard deviations of patients with UPS. The score on
the subscale ‘Role functioning physical’ was the lo-
west, and the score on the subscale ‘Role functioning
emotional’ the highest. This means that patients repor-
ted that their QoL was decreased the most by limi-
tations in functioning due to physical health, and the
least by limitations in functioning due to emotional
problems. However, the standard deviation of the sub-
scale ‘Role functioning emotional’ was the largest of all
subscales.
When the QoLwas summarized in utilities, the utilities
ranged from 0.37 to 0.96. The median of utilities was
0.57 and the mean was 0.58 (SD = .09).Healthcare-related costs
As Table 3 shows, patients with UPS consulted general
practitioners, medical specialists and physiotherapists
most. Almost all patients took medication, the most
commonly being for pain without inflammation inhib-
ition, for pain with inflammation inhibition, and for de-
pression/anxiety. The mean of healthcare-related costs
was estimated to be €3,122.93 (SD = €2,952.25) Per Pa-
tient Per Year (PPPY).Work-related costs
Of the 162 patients with UPS, 73 (45%) had paid work, 34
of whom (46.6%) reported absence from work; 9 (12.3%)
were partially absent, and 25 (34.3%) fully absent. In 15 of
the 73 (21%) employed patients, this full absence had
passed the end of the 23-week friction period. The mean
cost of productivity lost to absenteeism was estimated to
be €5,334.72 (SD = €11,980.95) per employed patient per
year, and €2,403.92 (SD = €8,442.89) PPPY (mean of the
total study group).
Most working patients with no or only partial ab-
sence reported lower on-the-job productivity; only se-
ven (14.6%) did not. The mean number of working hours
lost per working patient due to this presenteeism was
two hours per week (mean = 2.0;SD = 4.2) – over six
percent (mean = 6.3;SD = 12.7) of their contracted hours.
The mean cost of presenteeism was estimated to be
€1,899.16 (SD = €5,248.08) per employed patient per
year, and €855.79 (SD = €3,635.31) PPPY (mean of
the total study group).
Disability and reduced efficiency were also reported
in the performance of domestic tasks. Of the 162 pa-
tients with UPS, 89 (55%) asked other people to per-
form some domestic tasks for them for a duration of
four hours (mean = 4.3;SD = 12.3) per week. For only
21 of these 89 patients (24%), domestic tasks were per-
formed by paid professionals for a duration of almost
Table 1 Patients’ characteristics
Socio-demographic characteristic n %
Gender
Female 131 81%
Male 31 19%
Age in years (mean, SD) 45 11
Nationality
Dutch 141 87%
Other 21 13%
Marital status
Married or living with partner 110 68%
Unmarried, divorced or widowed 52 32%
Highest education completed
Primary school or less 14 9%
Lower vocational or general secondary education 54 33%
Intermediate vocational or higher general secondary
education
57 35%
Higher vocational, pre-university, or university education 36 22%
Missing 1 1%
Employment
Employed 73 45%
Unemployed 89 55%
Number of working hours per week of patients with
paid work (mean, SD)
23.9 10.9
Number of working days per week of patients with paid
work (mean, SD)
3.9 1.2
Clinical characteristic n %
Classification of UPS by SCID-I
Undifferentiated somatoform disorder 63 39%
Chronic pain disorder 99 61%
Duration of UPS in years (median, interquartile range) 9 3-16
Number of comorbid DSM-IV Axis I disorders
No comorbid DSM-IV Axis I disorder 95 59%
One or more comorbid DSM-IV Axis I disorders 67 41%
Number of comorbid DSM-IV Axis II disorders
No comorbid DSM-IV Axis II disorder 113 70%
One or more comorbid DSM-IV Axis II disorders 47 29%
Missing 2 1%
Referrer
Primary medical service 82 51%
Secondary medical service 51 31%
Secondary mental service 29 18%
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cost of paid substitution of domestic tasks was estimated
to be €433.27 (SD = €1,478.16) PPPY (mean of the total
study group).Total cost
The mean total cost was estimated to be €6,815.91 (SD =
€10,923.14) PPPY.
Discussion
Main findings: the burden of patients with UPS
The objective of our study was to assess QoL and costs
in a general sample of patients with UPS using generic
measures. Patients with UPS reported a poor QoL. Their
QoL was decreased the most by limitations in function-
ing due to physical health, and the least by limitations in
functioning due to emotional problems.
The healthcare-related cost was estimated to be
€3,122.93 (SD = €2,952.25) PPPY, which was based on
the number of visits to healthcare services and the medi-
cation use. While the eight medical specialist visits per
year in our study were comparable with the seven visits
found by Barsky et al. [10], the 15 primary care visits per
year in our study were much higher than the four found
by Barsky et al. [10]. Our findings on primary care visits
were more comparable with studies of high-utilizing pa-
tients with UPS [8,32], in which the mean number of
visits per year ranged from 13.6 [32] to 15.9 [8]. In con-
trast to the high number of primary care visits, the mean
number of 0.24 hospital days PPPY in our study was ex-
tremely low. Smith et al. [9] found a mean of 1.9 hospital
days per patient per three months. This difference might
be related to the fact that our sample was drawn from a
non-institutionalized population, which thus underrepre-
sented hospitalizations.
The work-related cost due to absenteeism was esti-
mated to be €2,403.92 (SD = €8,442.89) PPPY. The
work-related cost due to absenteeism was based on the
estimate of 67 disability days per employed patient per
year. This number of disability days found in our study
was comparable with the results of an earlier study [6],
which found 18.2 disability days per three months in pri-
mary care patients with UPS.
The work-related cost due to presenteeism was esti-
mated to be €855.79 (SD = €3,635.31) PPPY and that
due to paid substitution of domestic tasks was €433.27
(SD = €1,478.16) PPPY.
The mean total cost per patient with UPS per year was
estimated to be €6,815.91.
Our main findings in relation to the literature: the burden
of patients with UPS in comparison with other patient
groups
As the allocation of healthcare resources to patient
groups is partly based on who has ‘the highest burden’,
the burden of patients with UPS was compared with
other patient groups and the general population whose
QoL or costs had been measured in earlier studies using
comparable outcome measures.
Table 2 Patients’ means and standard deviations on
SF-36 subscales
SF-36 subscale Mean SD
Physical functioning 50.9 23.80
Role functioning physical 15.6 27.30
Bodily pain 33.2 19.57
General health 37.9 17.70
Vitality 33.4 17.86
Social functioning 49.2 24.42
Role functioning emotional 65.0 42.76
Mental health 62.7 20.14
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compared with those found in patients with major de-
pression, in patients with cancer, and in the general
population [22,33], resulting in Additional file 1. Accord-
ing to Osoba [34], the Minimally Important Difference
(MID) for SF-36 subscale scores is 10. MID is defined as
‘the smallest difference in score in the domain of interest
which patients perceive as beneficial and which would
mandate, in the absence of troublesome side effects and
excessive cost, a change in the patient’s management’ [35].
In comparison to other patient groups, patients with UPSTable 3 Healthcare visits and healthcare-related costs per pat
Healthcare service Percentage of patients
using the service
Mean visit
per year
General practitioner 58.64% 15.57
Medical specialist 38.89% 8.43
Physiotherapist 35.80% 14.12
Alternative health practitioner 22.84% 5.22
Company doctor 18.52% 2.97
Secondary community
mental-health service
11.11% 2.41
Private psychiatric/
psychotherapeutic practice
11.11% 2.49
Social worker 9.26% 2.01
Psychiatric outpatient clinic 8.64% 1.12
Self-help group 1.85% 0.32
Inpatient hospital care service 0.62% 0.24
Substance-abuse outpatient
care service
0.62% 0.08
Day hospital care service 0.00% 0.00
Medication Percentage of patients
using medication
Mean num
medication
Medication 85.19% 2.81
Medication with prescription 2.25
Medication without prescription 0.56
Total costs per patient
1)Costs are adjusted for base year 2007.had generally lower SF-36 subscale means, meaning a
poorer QoL. However, they did not differ a MID from
both other patient groups on the following subscales ‘Vi-
tality’, ‘Role functioning emotional’ and ‘Mental health’.
On the ‘Vitality’ subscale, patients with UPS and those
with major depression had comparable means that dif-
fered more than the MID from patients with cancer
who reported higher vitality. On the ‘Role functioning
emotional’ subscale, patients with UPS and those with
cancer had comparable means that differed more than
the MID from patients with major depression who re-
ported lower emotional functioning. On the ‘Mental
Health’ subscale, patients with UPS and those with can-
cer had comparable means that differed more than the
MID from patients with major depression who reported
lower mental health. Earlier studies that compared QoL
of patients with UPS with that of patients with major
depression [4-7] also found that patients with UPS re-
ported a poorer QoL in the physical domain and a re-
latively better QoL in the mental domain than patients
with major depression. Earlier studies that compared
QoL of patients with UPS with that of patients with
a medical diagnosis found that patients with UPS re-
ported a poorer QoL in all domains than those with a
medical diagnosis [8,9].ient with UPS per year
s per patient Mean costs per patient
per year in €1)
Percentage of
total costs
420.31 13.46%
584.96 18.73%
490.25 15.70%
248.30 7.95%
80.16 2.57%
396.94 12.71%
211.08 6.76%
125.74 4.03%
82.64 2.65%
16.26 0.52%
100.98 3.23%
2.13 0.07%
0.00 0.00%
ber different
per patient
Mean costs per patient
per year in €1)
Percentage of
total costs
363.17 11.63%
3122.93 100.00%
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with those found in patients with mental disorders and
chronic physical conditions and in the general population
[36-39], resulting in Additional file 2. According to Walters
and Brazier [40], the MID for SF-6D scores is 0.04. In com-
parison with other patient groups, patients with UPS had
generally a lower utility, meaning a poorer overall QoL.
The utility of patients with UPS was comparable to that of
patients with the following disorders: panic disorder, dys-
thymia, social phobia, any mood disorder, and cancer. The
utility of patients with UPS was more than the MID higher
than that of patients with major depression.
The healthcare-related cost of patients with UPS was
compared with the findings of the Cost of Illness study in
the Netherlands 2007 [41]. For this comparison, the cost
had to be expressed as a percentage of total Dutch annual
healthcare expenditure as shown in Additional file 3. The
proportion of total Dutch annual healthcare expenditure
associated with UPS was estimated to be over four per-
cent. This healthcare expenditure was compared with
those of all main disease categories and with those of pa-
tients with specific diseases and the general population
[41], resulting in Additional files 4 and 5. In comparison
with the healthcare expenditure of all main disease cat-
egories, the expenditure of patients with UPS was compar-
able to that of the category ‘blastomas; cancer and benign
tumors’ (see Additional file 4). In comparison with the
healthcare expenditure of patients with specific diseases
and the general population, only patients with dementia
and those with a mental retardation had higher healthcare
expenditure than patients with UPS (see Additional file 5).
The work-related cost due to absenteeism in paid work
of patients with UPS was compared with that found in
earlier studies in the general population, the healthy work-
force, and the workforce with chronic illness [42-45], using
the mean number of disability days and the mean percent-
age of absenteeism per patient per year. The percentage of
absenteeism is the number of lost working days due to ab-
senteeism divided by the number of working days accord-
ing to labor contract and expressed as a percentage. As
Additional file 6 shows, patients with UPS had the
highest number of disability days relative to that of
other reference populations, even if patients who had
passed the end of the friction period were excluded.
Also, patients with UPS had the largest percentage of
absenteeism compared with that of other reference
populations.
The work-related cost due to presenteeism in paid work
of patients with UPS was compared with that found in the
general population and the workforce with chronic illness
[43,44,46]. As Additional file 7 shows, the mean cost of
patients with UPS was higher than that of patients with
psychiatric disorders but lower than that of patients with
rheumatic arthritis.The work-related cost due to productivity loss in un-
paid work was calculated only if the unpaid work of pa-
tients with UPS was substituted by paid professionals.
Because other studies summed up the costs for both un-
paid and paid substitution [44,47], the resulting cost for
substitution of unpaid work of patients with UPS could
not be compared with that of different reference
populations.
Limitations and strengths in the study
A number of limitations merits attention. The data of
our cross-sectional study were collected from a ran-
domized controlled trial on the effectiveness of a
cognitive-behavioral group training and not from an
epidemiological study. As patients had to be referred to
this trial by a healthcare provider and patients had to
agree to take part in this treatment trial, our sample
might have been a selective group. Selection during the
referral could have both increased and decreased QoL
and costs; possible selection biases could have been only
referring patients with more severe symptoms and a
high healthcare utilization for reasons such as being
those most recognized by physicians as having UPS, or
only referring patients with mild symptoms for reasons
such as being best treatable in a relative short group
training. Also, selection during the acquirement of pa-
tients’ informed consent might have both increased and
decreased QoL and costs; possible selection biases could
have been only getting informed consent from patients
with more severe symptoms for reasons such as being the
most burdensome and eager to try treatment, or, alterna-
tively, only getting informed consent from patients with
mild symptoms for reason such as being the most vital to
show up at their first appointment. When looking at the
characteristics of our patient group, our patient group
seems to be rather a general than a selective sample. The
characteristics of our sample can be described as mainly
female, average age of 45 years, of whom 41% had a co-
morbid DSM-IV Axis I disorder and 29% had a comorbid
DSM-IV Axis II disorder. These characteristics are in line
with those found in other studies showing that UPS is
more prevalent in women in their forties [4,5,7,9,48], and
that 26 to 58% of the patients with UPS have a comorbid
DSM-IV axis I disorder and 37 to 88,6% have a comorbid
personality disorder [49-58]. Therefore, we believe that
our patient group is a representative group for adult pa-
tients with UPS as defined in our study.
UPS in our study was defined as physical symptoms
that fulfilled the DSM-IV criteria for an undifferentiated
somatoform disorder or for a chronic pain disorder. This
definition is stricter than the general used definition of
UPS which is physical symptoms that cannot be ex-
plained on the basis of a known medical condition. The
prevalence of both undifferentiated somatoform disorder
Zonneveld et al. BMC Health Services Research 2013, 13:520 Page 8 of 11
http://www.biomedcentral.com/1472-6963/13/520and chronic pain disorder in general practices totals 14.6%
[7], while the prevalence of UPS in primary care ranges
from 20 to 74% depending on the definition and methods
used to classify UPS [1]. As costs in our study were calcu-
lated using a prevalence of only 14.6%, the real total costs
associated with UPS might be higher, and the mean cost
per patient might be lower.
The QoL of patients with UPS was not adjusted for
sociodemographic characteristics such as age, gender, edu-
cation and living situation. Also, the QoL of the patient
groups used as reference was not adjusted for sociodemo-
graphic characteristics. Not adjusting for sociodemographic
characteristics might have affected our findings, as, in gen-
eral, patients who are older or have a low education report
a poorer QoL in the physical domain and patients who are
female or not living with a partner report a poorer QoL in
the mental domain [59]. Adjusting for the effects of socio-
demographic characteristics seems to be artificial, as some
illnesses, such as UPS and breast cancer, have different
prevalences in various sociodemographic groups. By elimin-
ating the effects of sociodemographic characteristics, results
will visualize the burden of the illness itself and not the bur-
den of patients, whereas treatments are indicated on the
latter condition.
QoL and costs were not adjusted for comorbid mental
and somatic disorders. As comorbidity reduces QoL
[7,59] and increases costs [10], the QoL might have been
lower and costs might have been higher due to the co-
morbidity prevalent in our study. However, isolating
these effects would also be artificial, as patients with
UPS suffer from many comorbid mental [54,60], and
somatic disorders [8,10].
Another potential limitation is that QoL and costs
were measured using self-report questionnaires. Poten-
tially, self-report is subject to errors caused by recall dif-
ficulties. Recall is easier: 1) if the time-period between
the event and the recall is shorter, a two-week interval
having been suggested as best; and 2) if events fluctuate
dramatically [61]. As the recall period of the question-
naire used on QoL and on the healthcare-related costs
was four weeks, and as work-related events are likely to
have fluctuated only slightly or moderately, errors in the
recall may have followed.
The self-report data on the volume of healthcare con-
sumption and production loss were extrapolated to esti-
mate their volume at a one-year interval, an approach
that would be appropriate only if the short intervals
were chosen at random and were thereby generalizable.
If this assumption was not met, the sample would have
produced an inaccurate estimation of the volume of
healthcare consumption and production loss.
Costs were estimated by multiplying the volume of
healthcare consumption with reference prices and by
multiplying the volume of production loss with theaverage productivity costs. Reference prices and product-
ivity costs are average national cost prices and not actually
paid prices. The advantage of the use of general cost prices
is that they are a valuable contribution to decision-making
at national level. However, the drawback is that they do
not result in the actually paid costs and are less valuable
for regional decision-making.
Work-related costs were based on a small sample of
patients that resulted partly from our use of the friction-
cost method, which reduced the number of employed
patients in the cost estimations. The small sample of
employed patients might also have been caused partly by
the long duration of UPS in our study group. As our pa-
tients had endured their symptoms for a long time, their
risk of losing paid employment due to symptoms had
been increased.
The standard deviations around the cost estimates were
large. This might be due to our relatively small sample size.
However, despite a large population-based sample, Smit
et al. [47] also found broad confidence intervals around
the cost estimates in their study of the cost of mental
disorders. Because cost-data have large standard errors,
they concluded that this is a common finding in health-
economic studies.
For the cost estimations, both conservative and less
conservative methods were used. A less conservative
method used in the cost estimation was to carry out the
recommendation of the TiC-P manual to assess costs at-
tributable to health problems in general, instead of those
only attributable to the target disease to overcome diffi-
culties for patients to distinguish between them. This
might have led to an overestimation of costs. On the
other hand, costs might also have been underrated by
other more conservative methods used. A conservative
method was the use of the friction-cost method, which
led us to count only the cost of an absence from work of
less than 23 weeks [24]. If we had counted absence from
work irrespective of its duration (the so-called human-
capital method), the number of patients with absen-
teeism would have doubled and the estimation of costs
would have been higher. Also, the work-related cost
due to presenteeism was estimated with a conservative
method. The TiC-P manual provides two methods to calcu-
late production loss due to presenteeism; the HLQ method
and the Osterhaus method. In the HLQ method, the num-
ber of hours needed to catch up with work as reported by
patients is used. In the Osterhaus method, the number of
days of hindrance due to health problems and efficiency on
these days as reported by patients is used. The study of
Osterhaus et al. [62] showed that the HLQ method was
more conservative and led to a lower cost estimation for
presenteeism than the Osterhaus method. Finally, the
work-related cost caused by substitution of domestic tasks
had been estimated in a conservative manner as only the
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estimation of costs. If the volume of total lost household
productivity was used, then the number of patients who
used substitution of domestic tasks would have been over
fourfold and the estimated costs would have been higher.
Another strength of our study is that we examined
QoL and costs in patients with UPS who were referred
both by primary and secondary services. The resulting
heterogeneous population made our results more ge-
neralizable than those of most studies that explored only
the burden of UPS in primary care [4-10].
QoL and costs were assessed using generic measures. By
using a generic measure for QoL which has the additional
advantage of representing the different domains of QoL in
one weighted score ‘utility’, our study made it possible to
compare patients with UPS with other patient groups to
evaluate ‘who is in greatest need’. By using a generic meas-
ure for costs which assesses not only a broad spectrum of
healthcare consumption but also production loss in paid
and unpaid work, the study made it possible to compare
patients with UPS with other patient groups to evaluate
‘who consumed which societal resources the most’.
The broad spectrum of cost-related outcomes, such as
the number of healthcare visits, disability days, working
hours lost to presenteeism in contrast to costs solely, have
all the additional advantage to be internationally compar-
able, i.e. across countries which have different healthcare
systems, healthcare services and labor markets. Presenting
information on QoL and costs for different patient groups
in quantified, unequivocal and comparable way helps pol-
itics and policymakers in their decision-making about al-
location of healthcare resources.
Conclusions
Information on QoL of specific patient groups and on the
costs associated with them, and on how these relate to
corresponding data in other patient groups is helpful in al-
locating healthcare resources. Our finding with regard to
patients with UPS – that their QoL was one of the poorest
of all patient groups – is a clear reminder that they are in
great need and that the allocation of sufficient resources is
justified. Interestingly, as their healthcare-related costs
were among the highest, they already use a high level of
resources. This seems to suggest that the solution is not
increasing healthcare expenditure on patients with UPS.
Instead, our findings raise the question whether current
resources are used properly, and whether these resources
should be reorganized to provide more effective and cost-
effective treatments for patients with UPS.
When looking at our data of QoL reported by patients
with UPS and the resources used by them, some hints
about how to properly allocate resources might be de-
duced. Our data showed that patients had a more physical
and social burden than an emotional one. Consistent withtheir burden, they searched for help in medical settings
which seemed to provide expensive and not effective help.
To reach patients with UPS, resources should be located
in medical settings but the services provided in these set-
tings should be improved.
An implementation of cognitive-behavioral therapy in
medical settings seems to be rational, because cognitive-
behavioral therapy is the most effective treatment
[48,63,64]. As research has shown that the effectiveness
of cognitive-behavioral therapy was difficult to replicate
when conducted by general practitioners [65-70], the cha-
llenge of reorganizing resources might be to introduce
psychologists specialized in cognitive-behavioral therapy
in medical settings. This might stop the organization of
healthcare services on the basis of the mind-body dualism,
which seems to be old-fashioned and expensive way of or-
ganizing and allocating resources.Additional files
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